mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
Bicalutamide |
FIMM |
pan-cancer |
AAC |
0.38 |
0.03 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.03 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.07 |
0.03 |
mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.03 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.03 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.03 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.03 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.03 |